Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M. Cruijsen; W. J.F.M. van der Velden; A. F.J. de Haan; S. K. Klein; M. Hoogendoorn; Y. Tromp; B. de Valk; B. van Rees; F. de Boer; E. van der Spek; J. Pruijt; L. F. Verdonck; E. Vellenga; N. Blijlevens; A. A. van de Loosdrecht; G. Huls

doi:https://doi.org/10.1080/10428194.2020.1775217

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M. Cruijsen, W. J.F.M. van der Velden, A. F.J. de Haan, S. K. Klein, M. Hoogendoorn, Y. Tromp, B. de Valk, B. van Rees, F. de Boer, E. van der Spek, J. Pruijt, L. F. Verdonck, E. Vellenga, N. Blijlevens, A. A. van de Loosdrecht, G. Huls

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	2752-2755
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	61
Issue number	11
DOIs	https://doi.org/10.1080/10428194.2020.1775217
Publication status	Published - Nov 2020

Access to Document

https://doi.org/10.1080/10428194.2020.1775217

Cite this

Cruijsen, M., van der Velden, W. J. F. M., de Haan, A. F. J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L. F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A., & Huls, G. (2020). Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Leukemia and Lymphoma, 61(11), 2752-2755. https://doi.org/10.1080/10428194.2020.1775217

@article{f016f0e3e063404c8e988310e01440a7,

title = "Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study",

author = "M. Cruijsen and {van der Velden}, {W. J.F.M.} and {de Haan}, {A. F.J.} and Klein, {S. K.} and M. Hoogendoorn and Y. Tromp and {de Valk}, B. and {van Rees}, B. and {de Boer}, F. and {van der Spek}, E. and J. Pruijt and Verdonck, {L. F.} and E. Vellenga and N. Blijlevens and {van de Loosdrecht}, {A. A.} and G. Huls",

year = "2020",

month = nov,

doi = "https://doi.org/10.1080/10428194.2020.1775217",

language = "English",

volume = "61",

pages = "2752--2755",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "11",

}

Cruijsen, M, van der Velden, WJFM, de Haan, AFJ, Klein, SK, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, LF, Vellenga, E, Blijlevens, N, van de Loosdrecht, AA & Huls, G 2020, 'Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study', Leukemia and Lymphoma, vol. 61, no. 11, pp. 2752-2755. https://doi.org/10.1080/10428194.2020.1775217

TY - JOUR

T1 - Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands

T2 - the OCEAN study

AU - Cruijsen, M.

AU - van der Velden, W. J.F.M.

AU - de Haan, A. F.J.

AU - Klein, S. K.

AU - Hoogendoorn, M.

AU - Tromp, Y.

AU - de Valk, B.

AU - van Rees, B.

AU - de Boer, F.

AU - van der Spek, E.

AU - Pruijt, J.

AU - Verdonck, L. F.

AU - Vellenga, E.

AU - Blijlevens, N.

AU - van de Loosdrecht, A. A.

AU - Huls, G.

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85087115531&partnerID=8YFLogxK

U2 - https://doi.org/10.1080/10428194.2020.1775217

DO - https://doi.org/10.1080/10428194.2020.1775217

M3 - Letter

C2 - 32530341

SN - 1042-8194

VL - 61

SP - 2752

EP - 2755

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 11

ER -

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

Access to Document

Other files and links

Cite this